Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 7, 2024 8:34 AM 2 min read

Sarepta Therapeutics To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday

by Avi Kapoor Benzinga Staff Writer
Follow

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Read More:

  • Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsPrice TargetPre-Market OutlookMarketsAnalyst RatingsTrading Ideasanalysts forecastsPT Changes
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
SRPT Logo
SRPTSarepta Therapeutics Inc
$17.66-0.73%
Overview
BE Logo
BEBloom Energy Corp
$138.17-1.12%
BROS Logo
BROSDutch Bros Inc
$53.15-0.09%
CROX Logo
CROXCrocs Inc
$96.80-0.08%
DUOL Logo
DUOLDuolingo Inc
$112.900.29%
DVN Logo
DVNDevon Energy Corp
$44.750.20%
LMND Logo
LMNDLemonade Inc
$63.950.30%
MCK Logo
MCKMcKesson Corp
$934.75-%
VERX Logo
VERXVertex Inc
$12.75-%
ZYME Logo
ZYMEZymeworks Inc
$22.841.08%
  • Piper Sandler boosted Duolingo, Inc. (NASDAQ:DUOL) price target from $271 to $351. Piper Sandler analyst Arvind Ramnani maintained an Overweight rating. Duolingo shares closed at $318.85 on Wednesday. See how other analysts view this stock.
  • B of A Securities cut the price target for Bloom Energy Corporation (NYSE:BE) from $8 to $7. B of A Securities analyst Julien Dumoulin-Smith maintained an Underperform rating. Bloom Energy shares closed at $10.97 on Wednesday. See how other analysts view this stock.
  • Needham raised the price target for Vertex, Inc. (NASDAQ:VERX) from $45 to $60. Needham analyst Joshua Reilly maintained a Buy rating. Vertex shares closed at $49.76 on Wednesday. See how other analysts view this stock.
  • Baird increased McKesson Corporation (NYSE:MCK) price target from $531 to $688. Baird analyst Eric Coldwell upgraded the stock from Neutral to Outperform. McKesson shares settled at $549.31 on Wednesday. See how other analysts view this stock.
  • TD Cowen raised Dutch Bros Inc. (NYSE:BROS) price target from $47 to $53. TD Cowen analyst Andrew Charles maintained a Buy rating. Dutch Bros shares closed at $34.94 on Wednesday. See how other analysts view this stock.
  • Truist Securities cut Devon Energy Corporation (NYSE:DVN) price target from $49 to $43. Truist Securities analyst Neal Dingmann downgraded the stock from Buy to Hold. Devon Energy shares closed at $40.02 on Wednesday. See how other analysts view this stock.
  • Cantor Fitzgerald raised the price target for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) from $152 to $167. Cantor Fitzgerald analyst Kristen Kluska upgradd the stock from Neutral to Overweight. Sarepta shares settled at $127.97 on Wednesday. See how other analysts view this stock.
  • Leerink Partners raised Zymeworks Inc. (NASDAQ:ZYME) price target from $10 to $25. Leerink Partners analyst Andrew Berens upgraded the stock from Market Perform to Outperform. Zymeworks shares closed at $15.61 on Wednesday. See how other analysts view this stock.
  • Loop Capital slashed the price target for Crocs, Inc. (NYSE:CROX) from $150 to $110. Loop Capital analyst Laura Champine downgraded the stock from Buy to Hold. Crocs shares closed at $102.74 on Wednesday. See how other analysts view this stock.
  • Keefe, Bruyette & Woods increased Lemonade, Inc. (NYSE:LMND) price target from $18 to $21. Keefe, Bruyette & Woods analyst Thomas McJoynt-Griffith downgraded the stock from Market Perform to Underperform. Lemonade shares closed at $29.29 on Wednesday. See how other analysts view this stock.
SRPT Logo
SRPTSarepta Therapeutics Inc
$17.66-0.73%
Overview
BE Logo
BEBloom Energy Corp
$138.17-1.12%
BROS Logo
BROSDutch Bros Inc
$53.15-0.09%
CROX Logo
CROXCrocs Inc
$96.80-0.08%
DUOL Logo
DUOLDuolingo Inc
$112.900.29%
DVN Logo
DVNDevon Energy Corp
$44.750.20%
LMND Logo
LMNDLemonade Inc
$63.950.30%
MCK Logo
MCKMcKesson Corp
$934.75-%
VERX Logo
VERXVertex Inc
$12.75-%
ZYME Logo
ZYMEZymeworks Inc
$22.841.08%
Comments
Loading...